Erich Tauber is founder and CEO of Themis Bioscience GmbH, Vienna. He is trained as Pediatrician, and is an Associate Professor of Clinical Pharmacology of the Medical University, Vienna.
His professional career, has and emphasis on vaccine development, and was responsible for the clinical development and licensing of the Japanese Encephalitis vaccine Ixiaro. In 2009, he has started the development boutique Themis, with the aim to identify academic projects and advance them into clinical proof-of-concept stage, where the projects should be partnered.
Lead projects are vaccines against Dengue and Chikungunya virus, where clinical proof of concept is expected for 2014.